Statements (47)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:fragrance
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:TEVA
|
| gptkbp:care_instructions |
inhale deeply and hold breath
|
| gptkbp:class |
beta-2 adrenergic agonist
|
| gptkbp:clinical_trial |
exercise-induced bronchospasm
rescue inhaler NC T00000512 acute bronchospasm maintenance therapy for asthma |
| gptkbp:contraindication |
hypersensitivity to albuterol
|
| gptkbp:dlc |
0093-2000-01
|
| gptkbp:dosage_form |
aerosol
|
| gptkbp:effective_date |
2006-03-01
|
| gptkbp:formulation |
metered-dose inhaler
|
| https://www.w3.org/2000/01/rdf-schema#label |
Pro Air HFA
|
| gptkbp:indication |
gptkb:asthma
gptkb:chronic_obstructive_pulmonary_disease_(COPD) |
| gptkbp:ingredients |
albuterol
|
| gptkbp:interacts_with |
MAO inhibitors
diuretics beta-blockers other sympathomimetics |
| gptkbp:label |
gptkb:Teva_Pharmaceuticals_USA,_Inc.
|
| gptkbp:manager |
inhalation
|
| gptkbp:manufacturer |
gptkb:Teva_Pharmaceuticals
|
| gptkbp:packaging |
pressurized metered-dose inhaler
|
| gptkbp:population |
shake well before use
prime inhaler before first use use as needed for asthma attacks |
| gptkbp:regulatory_compliance |
FDA approved
|
| gptkbp:safety_features |
may increase blood sugar levels
may cause hypokalemia monitor for paradoxical bronchospasm not for use in patients with severe asthma use with caution in patients with cardiovascular disorders |
| gptkbp:side_effect |
dizziness
headache nausea cough dry mouth nervousness tremors palpitations muscle cramps throat irritation |
| gptkbp:storage |
room temperature
|